Beta-blockers for preventing anthracycline-induced cardiotoxicity: a systematic review with network meta-analysis
Authors:
- Rafael Leite PachecoRPRafael Leite Pacheco
- Isabela Porto de ToledoITIsabela Porto de Toledo
- Roberta Borges SilvaRSRoberta Borges Silva
- Carolina de Oliveira Cruz LatorracaCLCarolina de Oliveira Cruz Latorraca
- Verônica ColpaniVCVerônica Colpani
- Ana Luiza Cabrera MartimbiancoAMAna Luiza Cabrera Martimbianco
- Remo Holanda de Mendonça FurtadoRemo Holanda de Mendonça Furtado
- Rachel RieraRRRachel Riera
Open Access
- 1 January 2025
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 71 (10)
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprololEuropean Heart Journal, 2016
- Carvedilol Administration Can Prevent Doxorubicin-Induced Cardiotoxicity: A Double-Blind Randomized TrialCardiology, 2016
- The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and ExplanationsAnnals of Internal Medicine, 2015
- Effect of carvedilol on silent anthracycline-induced cardiotoxicity assessed by strain imaging: A prospective randomized controlled study with six-month follow-upCardiology Journal, 2014
- Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control studyInternational Journal of Cardiology, 2013
- Protective Effect of Carvedilol on Adriamycin-Induced Left Ventricular Dysfunction in Children With Acute Lymphoblastic LeukemiaJournal of Cardiac Failure, 2012
- Protective Effect of Carvedilol in Cardiomyopathy Caused by Anthracyclines in Patients Suffering from Breast Cancer and LymphomaAmerican Heart Hospital Journal, 2011
- Cardioprotective effect of metoprolol and enalapril in doxorubicin‐treated lymphoma patients: A prospective, parallel‐group, randomized, controlled study with 36‐month follow‐upAmerican Journal of Hematology, 2010
- Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitroJournal of Molecular and Cellular Cardiology, 2004
- Expert consensus document on ?-adrenergic receptor blockersThe Task Force on Beta-Blockers of the European Society of CardiologyEuropean Heart Journal, 2004